Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPALisoMPO is distinct from other MPAL subtypes.

International journal of laboratory hematology - 1 Apr 2023

Weinberg Olga K, Dennis Jake, Zia Hamid, Chen Pu, Chu Andrew, Koduru Prasad, Luu Hung S, Fuda Franklin, Chen Weina

Abstract excerpt

INTRODUCTION: Myeloperoxidase (MPO) is considered a specific marker of myeloid/non-monocytic lineage in the diagnosis of mixed phenotype acute leukemia (MPAL). However, the clinical significance of isolated dim MPO expression in otherwise typical B lymphoblastic leukemia (B-ALL; referred to as B/myeloid MPALisoMPO ) in adult patients is unknown. METHODS: We compared flow cytometric immunophenotype and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Peroxidase

Share to Phenotype

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Identifiers

PMID: 36325594
DOI: 10.1111/ijlh.13988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPALisoMPO is distinct from other MPAL subtypes.PMID 36325594Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and PitfallsSemantic proximity Read ↗

[A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].Semantic proximity Read ↗

Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.Semantic proximity Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.Semantic proximity Read ↗

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.Semantic proximity Read ↗

Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.Semantic proximity Read ↗

Clinical and Molecular Characteristics of Patients with Mixed Phenotype Acute Leukemia.Semantic proximity Read ↗

Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.